Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Guengerich FP, Cheng Q (2011) Pharmacol Rev 63: 684-99 Copy number polymorphisms and anticancer pharmacogenomics. Gamazon ER, Huang RS, Dolan ME, Cox NJ (2011) Genome Biol 12: R46 An interview with P. Jeffrey Conn. Conn PJ (2012) Trends Pharmacol Sci 33: 119-21 A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development. Zhao B, Oxnard GR, Moskowitz CS, Kris MG, Pao W, Guo P, Rusch VM, Ladanyi M, Rizvi NA, Schwartz LH (2010) Clin Cancer Res 16: 4647-53 Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA (2010) Clin Cancer Res 16: 681-90 Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. Sangai T, Akcakanat A, Chen H, Tarco E, Wu Y, Do KA, Miller TW, Arteaga CL, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F (2012) Clin Cancer Res 18: 5816-28 F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials. Wang Y, Ayres KL, Goldman DA, Dickler MN, Bardia A, Mayer IA, Winer E, Fredrickson J, Arteaga CL, Baselga J, Manning HC, Mahmood U, Ulaner GA (2017) Clin Cancer Res 23: 3053-3060 Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA (2010) Ann Oncol 21: 864-70 The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development. Denny JC, Van Driest SL, Wei WQ, Roden DM (2018) Clin Pharmacol Ther 103: 409-418 Electronic medical records as a tool in clinical pharmacology: opportunities and challenges. Roden DM, Xu H, Denny JC, Wilke RA (2012) Clin Pharmacol Ther 91: 1083-86 Clinical pharmacology & therapeutics--an update. Stein CM (2003) Clin Pharmacol Ther 73: 1-3 Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors. Vilgelm AE, Washington MK, Wei J, Chen H, Prassolov VS, Zaika AI (2010) Mol Cancer Ther 9: 693-705 Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis. Man M, Close SL, Shaw AD, Bernard GR, Douglas IS, Kaner RJ, Payen D, Vincent JL, Fossceco S, Janes JM, Leishman AG, O'Brien L, Williams MD, Garcia JG (2013) Pharmacogenomics J 13: 218-26 Beyond traditional pharmacology: new tools and approaches. Gurevich EV, Gurevich VV (2015) Br J Pharmacol 172: 3229-41 Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges. Gamazon ER, Perera M (2012) Pharmacogenomics 13: 1101-4 The limits of genome-wide methods for pharmacogenomic testing. Gamazon ER, Skol AD, Perera MA (2012) Pharmacogenet Genomics 22: 261-72 Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study. Irvin MR, Zhang Q, Kabagambe EK, Perry RT, Straka RJ, Tiwari HK, Borecki IB, Shimmin LC, Stuart C, Zhong Y, Hixson JE, Arnett DK (2012) Pharmacogenet Genomics 22: 367-72 Organization, management and operation of contemporary academic mass spectrometry service facilities. Wood KV, Hachey DL (2000) J Mass Spectrom 35: 1157-64 Role of the General Clinical Research Center in teaching clinical management. Robertson D (1991) J Clin Pharmacol 31: 691-6 Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients. McLaughlin B, Gidday JM (2013) Transl Stroke Res 4: 104-13 The role of clinical pharmacology in molecular genetics. Robertson D (1997) Int J Clin Pharmacol Ther 35: 135-41
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.